Literature DB >> 25252961

Siglecs induce tolerance to cell surface antigens by BIM-dependent deletion of the antigen-reactive B cells.

Matthew S Macauley1, James C Paulson2.   

Abstract

Infusion of blood cells from a donor can induce humoral tolerance in a recipient and increase the probability of successful organ transplant, a clinical method defined as donor-specific transfusion (DST). Despite the clinical success of DST, the immunological mechanisms by which blood cells displaying a foreign Ag induce tolerance remain poorly understood. Based on recent findings showing that the B cell siglecs, CD22 and Siglec-G, can promote tolerance to Ags presented on the same surface as their ligands, we speculated that the B cell siglecs are key players in tolerance induced by DST. Using a variety of chemical and genetic approaches, we show that the B cell siglecs mediate tolerance to cell surface Ags by initiating an inhibitory signal that culminates in elimination of the Ag-reactive B cell. CD22 and Siglec-G are recruited to the immunological synapse by sialic acid ligands on the Ag-bearing cells, producing a tolerogenic signal involving Lyn and the proapoptotic factor BIM that promotes deletion of the B cell and failure of mice to develop Abs to the Ag upon subsequent challenge. We speculate that this tolerogenic mechanism is a contributing factor in DST and a mechanism of peripheral B cell tolerance to cell surface autoantigens.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25252961      PMCID: PMC4201975          DOI: 10.4049/jimmunol.1401723

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection.

Authors:  Benjamin D Ehst; Elizabeth Ingulli; Marc K Jenkins
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

3.  CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.

Authors:  Julia Jellusova; Ute Wellmann; Kerstin Amann; Thomas H Winkler; Lars Nitschke
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

4.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

5.  Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.

Authors:  Hans-Peter Marti; Jana Henschkowski; Gunter Laux; Bruno Vogt; Christian Seiler; Gerhard Opelz; Felix J Frey
Journal:  Transpl Int       Date:  2006-01       Impact factor: 3.782

6.  Sialoside analogue arrays for rapid identification of high affinity siglec ligands.

Authors:  Ola Blixt; Shoufa Han; Liang Liao; Ying Zeng; Julia Hoffmann; Satoshi Futakawa; James C Paulson
Journal:  J Am Chem Soc       Date:  2008-05-02       Impact factor: 15.419

7.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

Authors:  Brian E Collins; Ola Blixt; Alexis R DeSieno; Nicolai Bovin; Jamey D Marth; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

8.  Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.

Authors:  Laura T Martin; Jamey D Marth; Ajit Varki; Nissi M Varki
Journal:  J Biol Chem       Date:  2002-06-14       Impact factor: 5.157

9.  Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens.

Authors:  H E Armstrong; E M Bolton; I McMillan; S C Spencer; J A Bradley
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Inhibition of the B cell by CD22: a requirement for Lyn.

Authors:  K G Smith; D M Tarlinton; G M Doody; M L Hibbs; D T Fearon
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  21 in total

Review 1.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

2.  Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles.

Authors:  Takashi K Kishimoto; Joseph D Ferrari; Robert A LaMothe; Pallavi N Kolte; Aaron P Griset; Conlin O'Neil; Victor Chan; Erica Browning; Aditi Chalishazar; William Kuhlman; Fen-Ni Fu; Nelly Viseux; David H Altreuter; Lloyd Johnston; Roberto A Maldonado
Journal:  Nat Nanotechnol       Date:  2016-08-01       Impact factor: 39.213

3.  Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.

Authors:  Fernando Spiller; Corwin M Nycholat; Chika Kikuchi; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

Review 4.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

Review 5.  Sialic acids and autoimmune disease.

Authors:  Vinay S Mahajan; Shiv Pillai
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

6.  Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis.

Authors:  Kyle J Bednar; Corwin M Nycholat; Tadimeti S Rao; James C Paulson; Wai-Ping Fung-Leung; Matthew S Macauley
Journal:  ACS Chem Biol       Date:  2019-03-20       Impact factor: 5.100

7.  Characterization and statistical modeling of glycosylation changes in sickle cell disease.

Authors:  Heather E Ashwood; Christopher Ashwood; Anna P Schmidt; Rebekah L Gundry; Karin M Hoffmeister; Waseem Q Anani
Journal:  Blood Adv       Date:  2021-03-09

8.  Siglec-G represses DAMP-mediated effects on T cells.

Authors:  Tomomi Toubai; Corinne Rossi; Katherine Oravecz-Wilson; Cynthia Zajac; Chen Liu; Thomas Braun; Hideaki Fujiwara; Julia Wu; Yaping Sun; Stuart Brabbs; Hiroya Tamaki; John Magenau; Pang Zheng; Yang Liu; Pavan Reddy
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

10.  Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.

Authors:  Kyle J Bednar; Elena Shanina; Romain Ballet; Edward P Connors; Shiteng Duan; Joana Juan; Britni M Arlian; Michael D Kulis; Eugene C Butcher; Wai-Ping Fung-Leung; Tadimeti S Rao; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-09-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.